Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: MGL013
MIFTS: 50

Megalencephaly

Categories: Fetal diseases, Neuronal diseases, Rare diseases
Genes Variations Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Megalencephaly

About this section

MalaCards integrated aliases for Megalencephaly:

Name: Megalencephaly 55 60 30 6
Macroencephaly 60

Classifications:

MalaCards categories:
Global: Fetal diseases Rare diseases
Anatomical: Neuronal diseases
See all MalaCards categories (disease lists)
ICD10: 34 35
Orphanet: 60  
Rare neurological diseases
Developmental anomalies during embryogenesis


External Ids:

ICD10 34 Q04.5
ICD10 via Orphanet 35 Q04.5
UMLS via Orphanet 75 C0221355 C2720434
Orphanet 60 ORPHA2477
Sources

Summaries for Megalencephaly

About this section
NINDS : 55 Megalencephaly, also called macrencephaly, is a condition in which an infant or child has an abnormally large, heavy, and usually malfunctioning brain. By definition, the brain weight is greater than average for the age and gender of the child. Head enlargement may be evident at birth or the head may become abnormally large in the early years of life. Megalencephaly is thought to be related to a disturbance in the regulation of cell production in the brain. In normal development, neuron proliferation - the process in which nerve cells divide to form new generations of cells - is regulated so that the correct number of cells is produced in the proper place at the appropriate time. In a megalencephalic brain, too many cells are produced either during development or progressively as part of another disorder, such as one of the neurofibromatoses or leukodystrophies. Symptoms of megalencephaly include delayed development, seizures, and corticospinal (brain cortex and spinal cord) dysfunction. Megalencephaly affects males more often than females. Unilateral megalencephaly or hemimegalencephaly is a rare condition that is characterized by the enlargement of one side of the brain. Children with this disorder may have a large, asymmetrical head accompanied by seizures, partial paralysis, and impaired cognitive development. Megalencephaly is different from macrocephaly (also called megacephaly or megalocephaly), which describes a big head, and which doesn’t necessarily indicate abnormality. Large head size is passed down through the generations in some families.

MalaCards based summary : Megalencephaly, also known as macroencephaly, is related to megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 and megalencephaly-capillary malformation-polymicrogyria syndrome. An important gene associated with Megalencephaly is SCN1A (Sodium Voltage-Gated Channel Alpha Subunit 1), and among its related pathways/superpathways are PI3K-Akt signaling pathway and Focal Adhesion. The drugs Miconazole and Sirolimus have been mentioned in the context of this disorder. Affiliated tissues include brain, spinal cord and cortex, and related phenotypes are macrocephaly and short neck

Wikipedia : 77 Megalencephaly (or macrencephaly; abbreviated MEG) is a growth development disorder in which the brain... more...

Sources

Related Diseases for Megalencephaly

About this section

Diseases in the Megalencephaly family:

Megalencephaly, Autosomal Dominant

Diseases related to Megalencephaly via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 71)
# Related Disease Score Top Affiliating Genes
1 megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 33.9 CCND2 PIK3R2
2 megalencephaly-capillary malformation-polymicrogyria syndrome 33.6 PIK3CA PIK3R2
3 polymicrogyria 30.7 CCND2 PIK3R2
4 polyhydramnios, megalencephaly, and symptomatic epilepsy 12.5
5 leukoencephalopathy, cystic, without megalencephaly 12.5
6 megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 12.4
7 megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 12.4
8 macrocephaly/megalencephaly syndrome, autosomal recessive 12.4
9 hemimegalencephaly 12.3
10 megalencephaly, autosomal dominant 12.2
11 megalencephaly with dysmyelination 12.2
12 isolated megalencephaly 12.1
13 focal alopecia congenital megalencephaly 12.0
14 rnase t2-deficient leukoencephalopathy 11.9
15 megalencephalic leukoencephalopathy with subcortical cysts 1 11.9
16 cowden syndrome 1 11.6
17 alexander disease 11.6
18 macrocephaly, benign familial 11.3
19 pik3ca-related overgrowth spectrum 11.2
20 neurofaciodigitorenal syndrome 11.0
21 mental retardation, autosomal recessive 34, with variant lissencephaly 11.0
22 smith-kingsmore syndrome 11.0
23 macrocephaly, dysmorphic facies, and psychomotor retardation 11.0
24 early-onset parkinsonism-intellectual disability syndrome 11.0
25 hydrocephalus 10.5
26 polydactyly 10.5
27 epilepsy 10.2
28 autism 10.2
29 alacrima, achalasia, and mental retardation syndrome 10.1
30 tuberous sclerosis 10.1
31 polyhydramnios 10.1
32 achondroplasia 10.0
33 thanatophoric dysplasia, type i 10.0
34 periventricular nodular heterotopia 10.0
35 autism spectrum disorder 10.0
36 leukodystrophy 10.0
37 cleft palate, isolated 9.9
38 macrodactyly 9.9
39 nevus, epidermal 9.9
40 sturge-weber syndrome 9.9
41 tuberous sclerosis 1 9.9
42 ataxia-telangiectasia 9.9
43 canavan disease 9.9
44 sudden infant death syndrome 9.9
45 band heterotopia 9.9
46 polymicrogyria, bilateral temporooccipital 9.9
47 polyglucosan body myopathy 1 with or without immunodeficiency 9.9
48 lissencephaly 9.9
49 hypogonadotropic hypogonadism 9.9
50 lipomatosis 9.9

Graphical network of the top 20 diseases related to Megalencephaly:



Diseases related to Megalencephaly
Sources

Symptoms & Phenotypes for Megalencephaly

About this section

Human phenotypes related to Megalencephaly:

60 33 (show all 16)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 macrocephaly 60 33 hallmark (90%) Very frequent (99-80%) HP:0000256
2 short neck 60 33 hallmark (90%) Very frequent (99-80%) HP:0000470
3 frontal bossing 60 33 hallmark (90%) Very frequent (99-80%) HP:0002007
4 intellectual disability 60 33 hallmark (90%) Very frequent (99-80%) HP:0001249
5 delayed skeletal maturation 60 33 hallmark (90%) Very frequent (99-80%) HP:0002750
6 wide nasal bridge 60 33 hallmark (90%) Very frequent (99-80%) HP:0000431
7 dolichocephaly 60 33 hallmark (90%) Very frequent (99-80%) HP:0000268
8 prominent occiput 60 33 hallmark (90%) Very frequent (99-80%) HP:0000269
9 deeply set eye 60 33 hallmark (90%) Very frequent (99-80%) HP:0000490
10 abnormality of the fontanelles or cranial sutures 60 33 hallmark (90%) Very frequent (99-80%) HP:0000235
11 pointed chin 60 33 hallmark (90%) Very frequent (99-80%) HP:0000307
12 truncal obesity 60 33 hallmark (90%) Very frequent (99-80%) HP:0001956
13 genu valgum 60 33 frequent (33%) Frequent (79-30%) HP:0002857
14 macroorchidism 60 33 frequent (33%) Frequent (79-30%) HP:0000053
15 atrial septal defect 60 33 frequent (33%) Frequent (79-30%) HP:0001631
16 long penis 60 33 frequent (33%) Frequent (79-30%) HP:0000040

GenomeRNAi Phenotypes related to Megalencephaly according to GeneCards Suite gene sharing:

27 (show all 37)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability GR00055-A-2 10.34 PIK3CA
2 Decreased viability GR00173-A 10.34 PIK3R2
3 Decreased viability GR00221-A-1 10.34 PIK3CA PIK3R2 STRADA
4 Decreased viability GR00221-A-2 10.34 PIK3CA PIK3R2 STRADA
5 Decreased viability GR00221-A-3 10.34 STRADA
6 Decreased viability GR00221-A-4 10.34 PIK3CA PIK3R2 STRADA
7 Decreased viability GR00301-A 10.34 PIK3R2
8 Decreased viability GR00402-S-2 10.34 PIK3CA PIK3R2 STRADA
9 Decreased shRNA abundance (Z-score < -2) GR00366-A-165 10.13 PIK3R2
10 Decreased shRNA abundance (Z-score < -2) GR00366-A-191 10.13 SCN1A
11 Decreased shRNA abundance (Z-score < -2) GR00366-A-211 10.13 SCN1A STRADA
12 Decreased shRNA abundance (Z-score < -2) GR00366-A-216 10.13 SCN1A PIK3CA STRADA
13 Decreased shRNA abundance (Z-score < -2) GR00366-A-53 10.13 PIK3CA
14 Decreased shRNA abundance (Z-score < -2) GR00366-A-59 10.13 SCN1A
15 Decreased shRNA abundance (Z-score < -2) GR00366-A-60 10.13 PIK3CA
16 Decreased shRNA abundance (Z-score < -2) GR00366-A-62 10.13 PIK3R2 SCN1A
17 Decreased shRNA abundance (Z-score < -2) GR00366-A-86 10.13 PIK3R2
18 Decreased shRNA abundance (Z-score < -2) GR00366-A-91 10.13 STRADA
19 Increased shRNA abundance (Z-score > 2) GR00366-A-106 9.62 STRADA
20 Increased shRNA abundance (Z-score > 2) GR00366-A-116 9.62 PIK3CA
21 Increased shRNA abundance (Z-score > 2) GR00366-A-138 9.62 STRADA
22 Increased shRNA abundance (Z-score > 2) GR00366-A-157 9.62 PIK3CA
23 Increased shRNA abundance (Z-score > 2) GR00366-A-16 9.62 PIK3CA
24 Increased shRNA abundance (Z-score > 2) GR00366-A-166 9.62 PIK3CA
25 Increased shRNA abundance (Z-score > 2) GR00366-A-177 9.62 PIK3CA SCN1A STRADA
26 Increased shRNA abundance (Z-score > 2) GR00366-A-178 9.62 SCN1A
27 Increased shRNA abundance (Z-score > 2) GR00366-A-186 9.62 SCN1A
28 Increased shRNA abundance (Z-score > 2) GR00366-A-190 9.62 PIK3CA
29 Increased shRNA abundance (Z-score > 2) GR00366-A-214 9.62 SCN1A
30 Increased shRNA abundance (Z-score > 2) GR00366-A-29 9.62 SCN1A
31 Increased shRNA abundance (Z-score > 2) GR00366-A-42 9.62 PIK3CA
32 Increased shRNA abundance (Z-score > 2) GR00366-A-49 9.62 PIK3CA
33 Increased shRNA abundance (Z-score > 2) GR00366-A-73 9.62 STRADA
34 Increased shRNA abundance (Z-score > 2) GR00366-A-85 9.62 STRADA
35 Increased shRNA abundance (Z-score > 2) GR00366-A-93 9.62 SCN1A
36 Increased shRNA abundance (Z-score > 2) GR00366-A-99 9.62 SCN1A
37 Decreased cell migration GR00055-A-1 9.43 PIK3CA PIK3R2 STRADA
Sources

Drugs & Therapeutics for Megalencephaly

About this section

Drugs for Megalencephaly (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 9)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Miconazole Approved, Investigational, Vet_approved Phase 1, Phase 2 22916-47-8 4189
2
Sirolimus Approved, Investigational Phase 1, Phase 2 53123-88-9 46835353 6436030 5284616
3
Everolimus Approved Phase 1, Phase 2 159351-69-6 6442177 70789204
4 Anti-Bacterial Agents Phase 1, Phase 2
5 Anti-Infective Agents Phase 1, Phase 2
6 Immunosuppressive Agents Phase 1, Phase 2
7 Immunologic Factors Phase 1, Phase 2
8 Antibiotics, Antitubercular Phase 1, Phase 2
9 Antifungal Agents Phase 1, Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome Recruiting NCT02991807 Phase 1, Phase 2 RAD001;Placebo
2 Finding Genes With NGS Techniques in Whom Mutations Cause Neurological Diseases Unknown status NCT02340871
3 Genetics, Brain Structure and Thinking Skills in Autism Completed NCT01451983
4 North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 Recruiting NCT03548779 Not Applicable
5 A Natural History Study of the Gangliosidoses Recruiting NCT00668187
6 Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations Active, not recruiting NCT02461446

Search NIH Clinical Center for Megalencephaly

Sources

Genetic Tests for Megalencephaly

About this section

Genetic tests related to Megalencephaly:

# Genetic test Affiliating Genes
1 Megalencephaly 30
Sources

Anatomical Context for Megalencephaly

About this section

MalaCards organs/tissues related to Megalencephaly:

42
Brain, Spinal Cord, Cortex, Eye, Temporal Lobe
Sources

Publications for Megalencephaly

About this section

Articles related to Megalencephaly:

(show top 50) (show all 152)
# Title Authors Year
1
Recurrent mosaic MTOR c.5930C > T (p.Thr1977Ile) variant causing megalencephaly, asymmetric polymicrogyria, and cutaneous pigmentary mosaicism: Case report and review of the literature. ( 30569621 )
2019
2
Dysplastic megalencephaly phenotype presenting with prenatal high-output cardiac failure. ( 29594439 )
2018
3
Commentary on &amp;quot;Megalencephaly-capillary malformation-polymicrogyria syndrome: the first case report in Korea&amp;quot;. ( 29441111 )
2018
4
A Novel CCND2 Mutation in a Previously Reported Case of Megalencephaly and Perisylvian Polymicrogyria with Postaxial Polydactyly and Hydrocephalus. ( 29642246 )
2018
5
Novel Homozygous Deletion in STRADA Gene Associated With Polyhydramnios, Megalencephaly, and Epilepsy in 2 Siblings: Implications for Diagnosis and Treatment. ( 30311510 )
2018
6
Co-occurrence of mutations in FOXP1 and PTCH1 in a girl with extreme megalencephaly, callosal dysgenesis and profound intellectual disability. ( 30181650 )
2018
7
MYCN de novo gain-of-function mutation in a patient with a novel megalencephaly syndrome. ( 30573562 )
2018
8
A clinical review on megalencephaly: A large brain as a possible sign of cerebral impairment. ( 28658095 )
2017
9
A novel de novo germline mutation Glu40Lys in AKT3 causes megalencephaly with growth hormone deficiency. ( 28190287 )
2017
10
Spindle Misorientation of Cerebral and Cerebellar Progenitors Is a Mechanistic Cause of Megalencephaly. ( 28943256 )
2017
11
A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly. ( 28086757 )
2017
12
Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly. ( 28969385 )
2017
13
Olfactory nerve hypertrophy: a clue to the presence of ipsilateral megalencephaly. ( 29066644 )
2017
14
Mutations in CRADD Result in Reduced Caspase-2-Mediated Neuronal Apoptosis and Cause Megalencephaly with a Rare Lissencephaly Variant. ( 27773430 )
2016
15
Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism. ( 27159400 )
2016
16
Megalencephaly-capillary malformation-polymicrogyria syndrome: the first case report in Korea. ( 28018470 )
2016
17
Megalencephaly, polymicrogyria and ribbon-like band heterotopia: A new cortical malformation. ( 27381655 )
2016
18
Megalencephaly-capillary malformation polymicrogyria: A review and complex pediatric case report. ( 27216985 )
2016
19
Whole exome sequencing identifies the first STRADA point mutation in a patient with polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome (PMSE). ( 27170158 )
2016
20
Clinical, radiological and possible pathological overlap of cystic leukoencephalopathy without megalencephaly and Aicardi-GoutiA"res syndrome. ( 27091087 )
2016
21
Persistence of megalencephaly in a subgroup of young boys with autism spectrum disorder. ( 27273931 )
2016
22
Severe holocord syrinx in a child with megalencephaly-capillary malformation syndrome. ( 27035547 )
2016
23
HemA+megalencephaly assocA+ated wA+th fetal cardA+ac faA+lure and hydrops. ( 25710787 )
2015
24
Focal megalencephaly: intraoperative ultrasound imaging in epilepsy surgery. ( 26578502 )
2015
25
Detection of a mosaic PIK3CA mutation in dental DNA from a child with megalencephaly capillary malformation syndrome. ( 26351730 )
2015
26
Megalencephaly and Macrocephaly. ( 26060907 )
2015
27
Germline activating AKT3 mutation associated with megalencephaly, polymicrogyria, epilepsy and hypoglycemia. ( 25523067 )
2015
28
Three cases of right frontal megalencephaly: Clinical characteristics and long-term outcome. ( 26415548 )
2015
29
A nonsense variant in HERC1 is associated with intellectual disability, megalencephaly, thick corpus callosum and cerebellar atrophy. ( 26153217 )
2015
30
Sudden death in a case of megalencephaly capillary malformation associated with a de novo mutation in AKT3. ( 25416470 )
2015
31
Germline activating MTOR mutation arising through gonadal mosaicism in two brothers with megalencephaly and neurodevelopmental abnormalities. ( 26542245 )
2015
32
PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia. ( 25722288 )
2015
33
MEGALENCEPHALY, POLYMICROGYRIA, POLYDACTYLY AND HYDROCEPHALUS (MPPH) SYNDROME: A NEW CASE WITH OCCIPITAL ENCEPHALOCELE AND CLEFT PALATE. ( 26852507 )
2015
34
Abnormalities in the zinc-metalloprotease-BDNF axis may contribute to megalencephaly and cortical hyperconnectivity in young autism spectrum disorder patients. ( 25182223 )
2014
35
Unusual presentation of Sturge-Weber syndrome: Progressive megalencephaly with bilateral cutaneous and cortical involvement. ( 25024575 )
2014
36
Megalencephaly syndromes: exome pipeline strategies for detecting low-level mosaic mutations. ( 24497998 )
2014
37
Germline PTPN11 and somatic PIK3CA variant in a boy with megalencephaly-capillary malformation syndrome (MCAP) - pure coincidence? ( 24939587 )
2014
38
De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome. ( 24705253 )
2014
39
Megalencephaly and hemimegalencephaly: breakthroughs in molecular etiology. ( 24888963 )
2014
40
Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly. ( 23687350 )
2013
41
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome: a case report. ( 22859694 )
2013
42
Bilateral Periventricular Nodular Heterotopia With Megalencephaly: A Case Report. ( 23439715 )
2013
43
Expanding the differential diagnosis of fetal hydrops: an unusual prenatal presentation of megalencephaly-capillary malformation syndrome. ( 23754335 )
2013
44
The &amp;quot;megalencephaly-capillary malformation&amp;quot; (MCAP) syndrome: the nomenclature of a highly recognizable multiple congenital anomaly syndrome. ( 23798482 )
2013
45
Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP. ( 23592320 )
2013
46
Four-year follow-up of megalencephaly, polymicrogyria, postaxial polydactyly and hydrocephalus (MPPH) syndrome. ( 24092603 )
2013
47
Syndrome of megalencephaly, mega corpus callosum, and complete lack of motor development: exploring the phenotype. ( 24326961 )
2013
48
AKT3 and PIK3R2 mutations in two patients with megalencephaly-related syndromes: MCAP and MPPH. ( 23745724 )
2013
49
Genetics: mutations in mTOR pathway linked to megalencephaly syndromes. ( 22907262 )
2012
50
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. ( 22729224 )
2012
Sources

Variations for Megalencephaly

About this section

ClinVar genetic disease variations for Megalencephaly:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 SCN1A NM_001202435.2(SCN1A): c.3327dup (p.Ser1110Glnfs) duplication Pathogenic GRCh37 Chromosome 2, 166892659: 166892660
2 SCN1A NM_001202435.2(SCN1A): c.3327dup (p.Ser1110Glnfs) duplication Pathogenic GRCh38 Chromosome 2, 166036150: 166036150
Sources

Expression for Megalencephaly

About this section
Search GEO for disease gene expression data for Megalencephaly.
Sources

Pathways for Megalencephaly

About this section

Pathways related to Megalencephaly according to GeneCards Suite gene sharing:

(show all 50)
# Super pathways Score Top Affiliating Genes
1
PI3K-Akt signaling pathway 38
Show member pathways
 12.71 CCND2 PIK3CA PIK3R2
2
Focal Adhesion 1 38
Show member pathways
 12.62 CCND2 PIK3CA PIK3R2
3
Pathways in cancer 38
12.56 CCND2 PIK3CA PIK3R2
4
Glioma 38
Show member pathways
 12.4 CCND2 PIK3CA PIK3R2
5
Influenza A 38
Show member pathways
 12.3 CCND2 PIK3CA PIK3R2
6
MicroRNAs in cancer 38
12.23 CCND2 PIK3CA PIK3R2
7
mTOR signaling pathway (KEGG) 66
Show member pathways
 12.2 PIK3CA PIK3R2 STRADA
8
Prolactin Signaling Pathway 1 38
Show member pathways
 12.16 CCND2 PIK3CA PIK3R2
9
JAK-STAT signaling pathway (KEGG) 66
Show member pathways
 12.11 CCND2 PIK3CA PIK3R2
10
AMP-activated Protein Kinase (AMPK) Signaling 1
Show member pathways
 12.1 PIK3CA PIK3R2 STRADA
11
mTOR signalling 67
Show member pathways
 12.05 PIK3CA PIK3R2 STRADA
12
Development IGF-1 receptor signaling 23
Show member pathways
 12.02 CCND2 PIK3CA PIK3R2
13
Human T-cell leukemia virus 1 infection 38
12.01 CCND2 PIK3CA PIK3R2
14
MAPK Signaling: Mitogen Stimulation Pathway 66
Show member pathways
 11.88 CCND2 PIK3CA PIK3R2
15
Viral carcinogenesis 38
11.8 CCND2 PIK3CA PIK3R2
16
Sphingolipid signaling pathway 38
11.78 PIK3CA PIK3R2
17
Thyroid hormone signaling pathway 38
11.77 PIK3CA PIK3R2
18
TNF signaling pathway 38
11.74 PIK3CA PIK3R2
19
Insulin resistance 38
Show member pathways
 11.74 PIK3CA PIK3R2
20
HIF-1 signaling pathway 38
11.69 PIK3CA PIK3R2
21
AGE-RAGE signaling pathway in diabetic complications 38
11.69 PIK3CA PIK3R2
22
Amoebiasis 38
11.67 PIK3CA PIK3R2
23
Type II diabetes mellitus 38 1
Show member pathways
 11.67 PIK3CA PIK3R2
24
Small cell lung cancer 38
11.65 PIK3CA PIK3R2
25
PI3K / Akt Signaling 4
11.64 PIK3CA PIK3R2
26
Cellular senescence (KEGG) 38
11.64 CCND2 PIK3CA PIK3R2
27
Fc gamma R-mediated phagocytosis 38
11.63 PIK3CA PIK3R2
28
VEGF Pathway (Tocris) 73
Show member pathways
 11.58 PIK3CA PIK3R2
29
Bacterial invasion of epithelial cells 38
11.53 PIK3CA PIK3R2
30
Platinum drug resistance 38
11.52 PIK3CA PIK3R2
31
Human Thyroid Stimulating Hormone (TSH) signaling pathway 1
11.48 PIK3CA PIK3R2
32
IL2 signaling events mediated by PI3K 1
Show member pathways
 11.47 CCND2 PIK3CA
33
FoxO signaling pathway 38
Show member pathways
 11.47 CCND2 PIK3CA PIK3R2
34
Central carbon metabolism in cancer 38
11.45 PIK3CA PIK3R2
35
IL-2 Gene Expression in Activated and Quiescent T-Cells 65
Show member pathways
 11.4 PIK3CA PIK3R2
36
Role of phospholipids in phagocytosis 67
Show member pathways
 11.38 PIK3CA PIK3R2
37
Regulation of lipolysis in adipocytes 38
11.36 PIK3CA PIK3R2
38
Development_Leptin signaling via PI3K-dependent pathway 23
11.33 PIK3CA PIK3R2
39
Cell adhesion_Plasmin signaling 23
11.3 PIK3CA PIK3R2
40
IL-2 Signaling Pathway 1
Show member pathways
 11.26 CCND2 PIK3CA PIK3R2
41
Carbohydrate digestion and absorption 38
11.25 PIK3CA PIK3R2
42
G13 Signaling Pathway 1
11.21 PIK3CA PIK3R2
43
Aldosterone-regulated sodium reabsorption 38
11.16 PIK3CA PIK3R2
44
IL-10 Pathway 65
11.13 CCND2 PIK3R2
45
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities 1
11.02 PIK3CA PIK3R2
46
Telomere Extension by Telomerase 65
Show member pathways
 10.99 PIK3CA PIK3R2
47
DNA Damage Response (only ATM dependent) 1
10.86 CCND2 PIK3CA PIK3R2
48
Cytoskeleton remodeling_Role of PDGFs in cell migration 23
10.79 PIK3CA PIK3R2
49
Nephrin interactions 67
10.75 PIK3CA PIK3R2
50
Regulation of signaling by CBL 67
10.62 PIK3CA PIK3R2
Sources

GO Terms for Megalencephaly

About this section

Cellular components related to Megalencephaly according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 phosphatidylinositol 3-kinase complex GO:0005942 8.62 PIK3CA PIK3R2

Biological processes related to Megalencephaly according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein phosphorylation GO:0006468 9.54 CCND2 PIK3CA STRADA
2 phosphatidylinositol phosphorylation GO:0046854 9.4 PIK3CA PIK3R2
3 activation of protein kinase activity GO:0032147 9.32 PIK3CA STRADA
4 vascular endothelial growth factor receptor signaling pathway GO:0048010 9.26 PIK3CA PIK3R2
5 phosphatidylinositol-3-phosphate biosynthetic process GO:0036092 9.16 PIK3CA PIK3R2
6 phosphatidylinositol-mediated signaling GO:0048015 8.96 PIK3CA PIK3R2
7 phosphatidylinositol 3-kinase signaling GO:0014065 8.62 PIK3CA PIK3R2

Molecular functions related to Megalencephaly according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 phosphatidylinositol-4,5-bisphosphate 3-kinase activity GO:0046934 9.16 PIK3CA PIK3R2
2 1-phosphatidylinositol-3-kinase activity GO:0016303 8.96 PIK3CA PIK3R2
3 protein kinase activator activity GO:0030295 8.62 PIK3CA STRADA
Sources

Sources for Megalencephaly

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....